Pictet Asset Management (UK)’s Blueprint Medicines BPMC Stock Holding History

Pictet Asset Management (UK)’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$65.6M	Buy	745,696 +46,461	+7%	+$4.26M	0.07%	296
2021 Q1	$68M	Sell	699,235 -222,634	-24%	-$22.2M	0.08%	269
2020 Q4	$103M	Sell	921,869 -54,125	-6%	-$5.7M	0.13%	193
2020 Q3	$90.5M	Buy	+975,994	New	+$75.2M	0.14%	187
2020 Q1	–	Sell	-147,480	Closed	-$11.8M	–	1133
2019 Q4	$11.8M	Sell	147,480 -378,502	-72%	-$28.3M	0.02%	543
2019 Q3	$38.6M	Buy	525,982 +64,532	+14%	+$5.58M	0.08%	271
2019 Q2	$43.5M	Sell	461,450 -112,838	-20%	-$9.31M	0.09%	257
2019 Q1	$46M	Sell	574,288 -185,367	-24%	-$13.7M	0.1%	256
2018 Q4	$41K	Sell	759,655 -5,009	-0.7%	-$304K	0.1%	251
2018 Q3	$59.7M	Buy	764,664 +27,126	+4%	+$1.89M	0.13%	224
2018 Q2	$46.8M	Buy	737,538 +184,984	+33%	+$14.7M	0.11%	234
2018 Q1	$50.7M	Sell	552,554 -53,390	-9%	-$4.6M	0.13%	225
2017 Q4	$45.7M	Buy	605,944 +2,002	+0.3%	+$141K	0.12%	234
2017 Q3	$42.1M	Buy	603,942 +307,504	+104%	+$16.4M	0.12%	228
2017 Q2	$10.6M	Sell	296,438 -62,428	-17%	-$2.65M	0.03%	461
2017 Q1	$14.4M	Sell	358,866 -32,307	-8%	-$1.16M	0.05%	414
2016 Q4	$11M	Buy	391,173 +56,913	+17%	+$1.72M	0.04%	433
2016 Q3	$9.93M	Buy	334,260 +306,109	+1,087%	+$7.6M	0.04%	431
2016 Q2	$535K	Buy	+28,151	New	+$512K	﹤0.01%	820

Other funds holding BPMC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pictet Asset Management (UK)'s BPMC Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Blueprint Medicines (BPMC) stake by 6.6% in Q2 2021, buying an estimated $4.26M and bringing the position to 745,696 shares worth $65.6M. The position accounts for 0.07% of the portfolio, ranked #296.

Pictet Asset Management (UK) first reported a position in BPMC in Q2 2016 and has held it in 19 quarters since. The position peaked at $103M in Q4 2020. 281 funds tracked by Wall St. Rank hold BPMC as of Q2 2021.

Pictet Asset Management (UK) held 745,696 shares of Blueprint Medicines worth $65.6M as of Q2 2021.
Pictet Asset Management (UK) bought 46,461 Blueprint Medicines shares in Q2 2021, an estimated $4.26M.
Blueprint Medicines made up 0.07% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #296 holding.
Pictet Asset Management (UK) first reported a position in Blueprint Medicines in Q2 2016 and has held it in 19 quarters since.
Pictet Asset Management (UK)'s Blueprint Medicines position peaked at $103M in Q4 2020.
281 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.